Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. - Wikidata - awgldk - TriplyDB

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

http://www.wikidata.org/entity/Q34130552

about

Angiogenesis in male breast cancer Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer.Hemangiomas of infancy: clinical and biological characteristics.Sck is expressed in endothelial cells and participates in vascular endothelial growth factor-induced signaling.Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors.Antitumor and antiangiogenic activities of curcumin in cervical cancer xenografts in nude mice.The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials The effects of applying breast compression in dynamic contrast material-enhanced MR imaging Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies.Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues.Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.Soy isoflavones and cancer prevention.Antimelanoma Potential of Eruca sativa Seed Oil and its Bioactive Principles Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer.Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.Tumour angiogenesis, vascular biology and enhanced drug delivery.Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression.Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas.The antitumour activities of statins.Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.Motif mimetic of epsin perturbs tumor growth and metastasis In-vitro and in-vivo assays for angiogenesis-modulating drug discovery and development.The dynamic roles of angiopoietins in tumor angiogenesis.A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis.Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer.VEGF/VEGFR signalling as a target for inhibiting angiogenesis.Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.Small tyrosine kinase inhibitors as key molecules in the expression of metalloproteinases by solid tumors.Impact of heat-shock protein 90 on cancer metastasis Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.Cancer therapeutic antibodies come of age: targeting minimal residual disease.Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo.

P2860

Q24803467-70B10075-1BF5-4CD2-BCC0-4F13D4828938 Q28200101-16F6F6D0-BED7-424E-9CB2-A68FD99F69CD Q28216853-F238DC6B-E6D6-48EC-BAF6-FC5A3F2C8AD4 Q30724325-80D192DF-2D68-49C0-87B3-5D86C09D27CE Q33228482-3D22B447-5709-4DC7-9EE7-F8C049C6ABE0 Q33292515-FD943F74-27EC-4C6C-AE0F-DAC3E65BAAE1 Q33466404-B95E294B-13A7-4010-A701-DFC6F05A718D Q33563034-C3583EC5-884A-4BF6-9616-EEE852284B85 Q34020783-A1397270-B012-4645-B7FB-01204A1B3A98 Q34066152-D6B4C86C-5323-4D85-BFD9-D2667D4FDFA2 Q34072703-8AE9D6DB-96AB-4268-96C0-CE9B66F99E87 Q34443645-280AB987-1311-4369-B2B5-66DD593E1A8D Q34494774-85FC2166-310D-47DB-B7A0-521A2C4B7D63 Q34681250-F3E6D6EB-CE65-42E8-BC42-EB8789B987C2 Q34975344-47D88010-E4CA-4120-85D4-72C1754D7213 Q35165994-680C78E0-08D5-486E-8DF6-86B6747C9575 Q35233993-AC4D20EB-3003-4E52-AE44-609888C67174 Q35589203-CA50560C-A4D5-4754-9D48-E5390CB77173 Q35641273-63FD4993-43D0-4050-9323-C0A5AE016465 Q35803396-6971E215-CC2B-41EB-AE8D-1C1BDACB56D4 Q35896210-0C3BBE21-55C3-42CE-B8EE-068D1A782E4C Q35931998-0043109E-C9B4-48C3-9D4A-1EB0A3ADE35C Q36072768-F260390A-A062-4A52-89D4-9C6B3DEC7F6B Q36190783-3409B35F-C458-4E51-A9C3-9DC748D43299 Q36256400-BCA45A1E-0203-4251-BDCE-BE471B95CA4E Q36321375-B2518509-8F87-451D-9D21-13031EE26F49 Q36335923-3BD5ADE6-690C-46B2-A831-11788D37C86D Q36384017-52848511-78A6-4C1C-9A70-0EE336EE5877 Q36429528-D46A397C-9A25-411A-BE5B-3BC32B45B323 Q36653663-44283B0A-2B5B-4B19-919E-A4B1588EFD08 Q36671553-82FAEF4B-9513-4371-A03B-DE470A8FBC52 Q36677407-E4B7D5FE-3629-4162-8DB0-86B1A3677972 Q37003601-88027FD6-F8F4-4CC1-AB32-37267507BCF3 Q37035753-AF173593-5692-49E1-8DDD-DBE456C2EE9B Q37212927-58CD0FB0-1058-4190-AC6A-E26A200816A0 Q37228581-C42272EC-E35C-4226-B7D1-3A7B81885316 Q37272247-4177AC90-8B13-4853-AA6E-99A0B8E33ECA Q37328125-31FEF0D9-6FD9-492B-8613-F6101926E0AD Q37453793-75F04B47-982B-486E-9B6D-3EF87EA47E8A Q38282838-BF75960D-BE71-4B45-AA57-A8B49C389E22

P2860

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

http://www.wikidata.org/entity/Q34130552

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@ast

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@en

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@nl

type

label

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@ast

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@en

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@nl

prefLabel

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@ast

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@en

Mechanisms of angiogenesis and ...... f tumor growth and metastasis.

@nl

P1433

Q34130552-FF04BE0B-F32A-4E01-8C77-952582CA34D5

P1476

Q34130552-2941F087-5F33-498F-B3E2-C2BC405AB367

P2093

Q34130552-67E75492-7800-4E1C-B078-1864E1F43D95

Q34130552-82446FCB-7899-4206-80E3-13990E22DBBC

P2860

Q34130552-0002167A-723B-4CBD-8CE3-52BD9D70D74B

Q34130552-02A97854-106A-429D-923F-7B9EF44A056E

Q34130552-07475FFB-5A9A-4D92-9AAE-AB2ED23975F6

Q34130552-0C51DD86-3A77-4266-94AE-8EAFD1B2310D

Q34130552-1221489D-3B7E-48E0-8FC2-E8CA976CF00A

Q34130552-17B49A73-CA11-4D0D-BF51-40ABF71F5197

Q34130552-1BDCA3FB-C54B-4473-AC6D-61D589681C1A

Q34130552-1DC3A277-5D8B-465F-8382-D6DDA1D2E80E

Q34130552-214066F4-DF2D-4F14-9AEC-7579EB0C10FF

Q34130552-21738B31-7839-4279-8EA1-49066980ABC8

P2888

Q34130552-08D43FDE-7476-4F97-8F95-87B80EB01555

P304

Q34130552-877DA332-3B33-4A0A-9840-8DCB59E74768

P31

Q34130552-5BA78080-9324-4EB5-874D-26426CD390D4

P356

Q34130552-30421F07-FF44-495C-9BD4-3CC2A6E76D8E

P407

Q34130552-8849CE93-2A90-4179-9700-A1C7EB847705

P433

Q34130552-661120B9-CB9E-4783-A101-DCAF02C8FBB1

P478

Q34130552-A78BC6DF-F183-42C6-9F8D-8F77C7D82E4F

P50

Q34130552-DF4B6C65-7878-414A-BA79-9DF1BD25AD56

P577

Q34130552-18254B19-FD18-4841-849B-F4D96857BE44

P5875

Q34130552-F1C341A6-FA6E-485B-A42D-25592645AB30

P6179

Q34130552-807289E2-884E-4774-9D2A-21866D968536

P698

Q34130552-71B1B017-B477-4402-A752-03786E2EBF0F

P356

P1433

P1476

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis

@en

P2093

Karpanen T

http://www.w3.org/2001/XMLSchema#string

Saaristo A

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3

Angiopoietins 3 and 4: diverging gene counterparts in mice and humans

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

P2888

P304

6122-6129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1203969

http://www.w3.org/2001/XMLSchema#string

P407

P433

53

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12172203

http://www.w3.org/2001/XMLSchema#string

P6179

1034156048

http://www.w3.org/2001/XMLSchema#string

P698

11156525

http://www.w3.org/2001/XMLSchema#string